Overall, we have not shown any significant relationship between negative TPO or TG antibody tests, or low serum titres of either antibody, and eye signs, in patients with GD, Hashimoto thyroiditis or transient thyroiditis. TPO and TG antibodies are thus unlikely to play a major role in the pathogenesis of GO.
Introduction
Inflammation of the Orbital Connective Tissue (OCT) and fat, extraocular muscles and the levator palpebrae superioris muscle in the upper eyelids occurs in about 40% of patients with Graves hyperthyroidism [1] [2] [3] while generally mild eye signs or isolated Upper Eyelid Retraction (UER) occurs in about 25% of patients with Hashimoto thyroiditis [4] and, occasionally, in patients with transient thyroiditis [5] . The best name for this disorder is "Thyroid-Associated Ophthalmopathy (TAO)". In about 10% of cases, the eye changes occur in the apparent absence of thyroid autoimmunity, so-called "euthyroid Graves disease" [3] . The mechanism for autoimmune-mediated inflammation in the eye muscles and OCT and fat is unclear but a popular hypothesis is that autoimmunity against the TSH-Receptor (TSHR) expressed in the orbital pre adipocytes and fibroblasts [6] [7] [8] , or eye muscle cell [9] , may initiate the inflammatory changes. While the extra ocular muscle reaction, which can occur in the absence of OCT and fat inflammation, may be a separate TAO subtype [10, 11] , it has not been shown conclusively that the two types differ from Nunery types 1 (mainly involving the orbital fat without restrictive myopathy) and 2 (with diplopia and restrictive myopathy) [12] . Earlier, we showed that chronic UER can be the dominant or only eye sign, except for mild proptosis, in patients with Graves Disease (GD), Hashimoto thyroiditis and transient (sub acute, silent) thyroiditis [13] .
Theories to explain the development of ophthalmopathy in patients with Graves' hyperthyroidism must take into account this unique association. Many workers have investigated the possible existence of auto antigens that are expressed in both the thyroid and orbit [5, [13] [14] [15] . Such antigens include the TSHR [7, 8, 16] , the 64-kDa protein, now identified as the Flavoprotein (Fp) sub-unit succinate dehydrogenase [17] or some other, as yet unidentified, thyroid and eye muscle shared cell membrane antigen. Another recently identified target antigen in TAO is type XIII collagen which is expressed in the surface of the orbital fibroblast [18] where it could be seen by the immune system, leading to antibody production, glycosaminoglycans production, fibroblast stimulation and orbital scaring [19, 20] .
Because of this link with thyroid inflammation some workers have addressed the possibility of a relationship between antibodies targeting the thyroid antigens, Thyroid Peroxidase (TPO) and 
Methods
TPO and TG antibodies were measured using a Standard Enzyme-Linked Immunosorbent Assay (ELISA) in 84 well-characterised patients 39 with Graves' Disease (GD), 33 with Hashimoto thyroiditis and 12 with transient (subacute, silent) thyroiditis, with and without eye signs.
Results
Twenty-one % of GD patients with active ophthalmopathy and 30% of those without eye signs had negative TPO antibody tests and the ranges of titres and mean titres were similar in the two groups, for both antibodies. Although the prevalence of negative TPO antibody tests in patients with long standing (chronic) Graves disease and ophthalmopathy (67%) was greater than that in patients with long standing hyperthyroidism but no eye signs (20%) this difference was not statistically significant, possibly because the group sizes were small. In patients with Hashimoto thyroiditis and transient (sub acute, silent) thyroiditis the prevalence's of negative TPO antibody tests, range of titres and mean (+/-SE) titres, were again not significantly different between those with and without eye signs for either disorder. Similar results were found for TG antibodies in all groups of patients, with no significant differences between those with and without ophthalmopathy.
Thyroglobulin (TG) and ophthalmopathy. Indeed, we have recently shown that high serum levels of TPO antibodies were protective against the development of UER but not ophthalmopathy [21] . Earlier, Khoo et al., [22, 23] proposed that the combination of negative anti-TPO antibody tests or low titres of TPO antibodies, positive TSHR antibodies and smoking, indicates high risk for ophthalmopathy. However, others [24, 25] have failed to confirm these findings and a relationship between thyroid antibodies and the eye disorder is not proven. Here, we have addressed a possible relationship between TPO and TG antibodies, ophthalmopathy and chronic UER in patients with GD, Hashimoto thyroiditis and transient thyroiditis.
Clinical Subjects and Methods
The patients were seen over a four-year period from 2002-2006 at the thyroid clinic at Nepean Hospital, Kingswood, and the Geelong Hospital, Geelong, Australia. The following groups of patients were studied;
1. Thirty-nine patients with GD, 6 males and 33 females, aged (mean age 47 yrs), 34 with recent onset disease and 5 with long standing (chronic) disease, of whom 24 had some eye signs, namely, active ophthalmopathy in 14, chronic ophthalmopathy in 6, dominant chronic UER in 16, which was the only eye sign except for mild proptosis in 4 of the patients. Fifteen of the patients, 10 with recent onset disease and 5 with long-standing hyperthyroidism, had no eye signs.
Thirty-three patients with Hashimoto thyroiditis, 3 males and 30
females, aged 10-75 (mean age 49 yrs) of whom 4 had active ophthalmopathy and 14 chronic UER, which was the only eye sign in 11 of the patients.
3. Twelve patients with transient thyroiditis namely, 5 with Subacute Thyroiditis (SAT) and 7 with Silent Thyroiditis (ST), one male and 11 female aged 24-68 (mean age 43 yrs) of whom 7 had active ophthalmopathy and 4 had chronic UER but no other features of ophthalmopathy.
The diagnoses of the various disorders were based on standard clinical criteria and confirmed by thyroid function testing, real-time thyroid ultrasonography and immunological tests. The ophthalmopathy was classified as; a) "active" [signs present for <6 months, Clinical Activity Score (CAS) ≥3] or "chronic" (signs present for >12 months, CAS < 3]; and b) Nunery types 1 (mainly involving the orbital fat without restrictive myopathy) or 2 (with diplopia and restrictive myopathy) [12] . UER was identified as an important sign of thyroid eye disease that can occur in association with other features or as an isolated abnormality, especially in patients with Hashimoto thyroiditis. In patients with Graves hyperthyroidism UER had been present for at least 3 months after they had become euthyroid (with normal TSH). The degree of exophthalmos (mm) was measured using a Hertel exophthalmometer. Nepean and Geelong Hospitals Human Ethics Committees approved the retrospective study. Consent forms were not required.
Thyroglobulin and thyroid peroxidase antibody measurements
Serum TG and TPO antibodies were measured by Barratt & Smith Pathology, Sydney, Australia, using commercial kits according to the manufacturers' instructions. A positive test was taken as a tire of >20, for both antibodies.
Other tests
Plasma free Thyroxin (fT4) and Thyrotropin (TSH) were measured by Barratt & Smith Pathology, Sydney, Australia, using commercial kits according to the manufacturers' instructions.
Statistical analysis
Statistical analysis was carried out using SigmaStat (version 2.0; Jandel Co., San Rafael, CA, USA). Mean (± SE) antibody titres for groups of patients were compared using the Mann-Whitney non-parametric test. Prevalences of positive antibody tests in the various groups were compared statistically using the X 2 test or the Fishers exact test for five or less expected observations in one or more cells. In all tests, a p-value of <0.05 was taken as significant.
Results
We have analysed the relationship between TPO and TG antibodies and ophthalmopathy and chronic UER in patients with GD, Hashimoto thyroiditis and transient (sub acute, silent) thyroiditis (sub acute thyroiditis is not an autoimmune disease). TPO and TG antibody results were expressed as serum titre, a cut off value of >20 being taken as positive, for both antibodies. Patient demographics, any treatment, eye signs, smoking status and serum titres of TG and TPO antibodies for GD are summarised in table 1, for Hashimoto thyroiditis in table  2 and for patients with transient thyroiditis in table 3 . In this study we were particularly interested in the prevalence's of negative antibody tests in patients with thyroid autoimmunity and ophthalmopathy or isolated UER. The prevalence's of negative TPO and TG antibody tests In patients with recent onset Graves hyperthyroidism, the prevalence's of negative TPO antibody tests in those with (n=14), and without (n=10), active ophthalmopathy were 21% and 30%, respectively, which were not significantly different ( X 2 test, p=NS) 
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• (Table 4 ). In those with chronic disease, i.e., long standing hyperthyroidism (>2 yr since diagnosis, CAS <3), with (n=6) and without (n=5) ophthalmopathy of >12 months duration, the prevalence's were 67% and 20%, respectively, which were not significantly different (Fischer exact test, p=NS). TG antibodies were more often undetectable, or positive at a lower titre, than TPO antibodies, but the same trends were seen and there were no significant differences in prevalence's of negative tests between any of the 4 groups (X 2 tests, p=NS) ( Table 4) . As seen in table 1, the range of titres was similar in patients with Graves' disease with or without ophthalmopathy or UER, for both antibodies.
In patients with Hashimoto thyroiditis, in whom any eye signs were generally mild or manifest as isolated UER (Table 2) , there were no significant differences between prevalence's of negative tests (Table 4) or range of titres (Table 2) , for either antibody. While there was a tendency for high titres of TPO antibodies (≥ 6400) to be protective for UER, but not ophthalmopathy (Table 2) , this was not statistically significant (X 2 tests, p=NS). In patients with transient thyroiditis, there were again no significant differences in the range of titres (Table 3) or prevalence of negative antibody tests (Table 4) in patients with and without ophthalmopathy or isolated UER for either antibody X 2 tests, p=NS (Figure 1 Considering all patients with chronic UER (with or without other signs of ophthalmopathy) associated with Graves hyperthyroidism, Hashimoto thyroiditis or transient thyroiditis there were no significant relationships between this eye sign and either negative antibody tests or range of titres (Tables 1-3 ) for either antibody. As shown in figure 1 , mean (± SE) for the various groups of patients with and without ophthalmopathy or UER were not significantly different from each other (Mann-Whitney test, all p=NS) (Figure 1) .
Finally, more patients with Graves disease and ophthalmopathy were smokers (39 % vs. 8 % of patients without eye signs), which was slightly greater (42%) when only ophthalmopathy was considered and slightly less (27%) when UER was considered (25%). All 5 patients with GD, Hashimoto thyroiditis or silent thyroiditis who smoked and had negative TPO antibody tests had eye signs namely, chronic UER in one, congestive ophthalmopathy (Nunery type 1) in two and congestive ophthalmopathy and eye muscle dysfunction (Nunery type 2) in two patients.
Discussion
The main thyroid antibodies are those targeting TPO in the follicular cell membrane, TG in the colloid and the TSHR in the thyroid follicular cell membranes. The latter is associated with hyperthyroidism and serum antibodies against TPO and TG are markers for the thyroid autoimmune process of Hashimoto thyroiditis and GD. Low titres of thyroid antibodies are sometimes found in patients with sub acute thyroiditis and, more often, in those with silent thyroiditis in whom titres tend to increase with time. TPO antibodies have been shown to be cytotoxic to thyroid cells in vitro [26] thus likely to play a role in the development of hypothyroidism in patients with Hashimoto thyroiditis. While TG antibodies are less often positive, or positive but in low titres, than TPO antibodies, in all 3 disorders, they are also markers of the thyroid autoimmune process, but probably not directly pathogenetic. Khoo et al., [22, 23] reported that TPO antibodies were negatively related to ophthalmopathy namely, that low titres, or undetectable antibodies, were risk factors for the development of ophthalmopathy, particularly in patients with TSHR antibodies who smoked. These workers postulated that TPO antibodies were somehow protected against ophthalmopathy. Our findings, reported here, do not support such a hypothesis as we find no close relationship between either antibody and active ophthalmopathy or UER in patients with GD, Hashimoto thyroiditis or transient thyroiditis. We found that antibody titres were similar for patients with GD with and without active eye signs (ophthalmopathy and/or UER), for both antibodies. Although we previously reported that a TPO antibody titre of >400 was protective of UER but not ophthalmopathy in patients with Hashimoto thyroiditis but not Graves disease [21] , this was not reproduced here, possibly because of the small numbers of patients studied.
Our findings generally support those of Ekstein et al., [24] and Wright-Pascoe et al., [25] who found no close relationship between TPO and TG antibodies and ophthalmopathy. Indeed, the latter group found a positive relationship between both TPO and TG antibodies and ophthalmopathy in patients with GD. Although 67% of a small group of patients with chronic GO in our study had negative anti-TPO antibodies compared to 20% of those with long-standing hyperthyroidism without eye signs (100% vs. 44% for TG antibodies), this was not significant possibly because of the small group sizes and wide range of titres.
The finding that all 5 patients with GD, Hashimoto thyroiditis or transient thyroiditis and negative TPO antibody tests who smoked had eye signs suggests that this combination does indicate high risk for eye signs in this group of patients. Smoking is a definite risk factor for ophthalmopathy [27, 28] , and we report here for the first time a modest relationship between smoking and chronic UER as a dominant feature of ophthalmopathy. It is likely that the association reported by Khoo et al., [22, 23] reflects this, rather than a role of TPO antibodies per se. In conclusion, our study did not confirm a significant relationship between ophthalmopathy and thyroid antibodies in patients with GD, Hashimoto thyroiditis or transient (sub acute, silent, post partum) thyroiditis. Future studies should focus on the nature and significance of specific autoimmunity against eye muscle and orbital fibroblast antigens in patients with ophthalmopathy -including those with so-called euthyroid Graves' disease -and the related chronic upper eyelid disorder that is so common in patients with Hashimoto thyroiditis.
